glp-1 medicaid What to Know About the BALANCE Model for GLP-1s in Medicare and and the Medicare Bridge How the Medicare GLP-1 Bridge
Description
Tirzepatide is a dual action GLP-1 and GIP receptor agonist

Balances the gut microbiome*

High-Potency Formula Provides Akkermansia muciniphila plus chicory inulin for targeted microbiome support

Outcomes included total and early-phase (060min) areas under the curve (AUCs) and peak concentrations